Notably, although IGF1R degradation was evident in implanted tumours, the PROTABs were well tolerated (Extended Data Fig. 2k) and no measurable IGF1R degradation was observed in the normal colonic mucosa (Fig. 2h, i). This evidence concerns the gene IGF1R and neoplasm.